Evidence map›Paper›PMID 32290085›Full record

ArticleCells2020

Noggin Inhibits IL-1β and BMP-2 Expression, and Attenuates Cartilage Degeneration and Subchondral Bone Destruction in Experimental Osteoarthritis.

Szu-Yu Chien, Chun-Hao Tsai, Shan-Chi Liu, Chien-Chung Huang, Tzu-Hung Lin, Yu-Zhen Yang, Chih-Hsin Tang

Open access · goldAbstract read
In one paragraph

Article in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 95 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Szu-Yu ChienDepartment of Exercise Health Science, National Taiwan University of Sport, Taichung 404393, Taiwan.
Chun-Hao TsaiDepartment of Orthopedic Surgery, China Medical University Hospital, Taichung 404022, Taiwan.ORCID 0000-0002-4428-3132
Shan-Chi LiuDepartment of Medical Education and Research, China Medical University Beigang Hospital, Yunlin 651012, Taiwan.
Chien-Chung HuangSchool of Medicine, China Medical University, Taichung 404022, Taiwan.
Tzu-Hung LinMaterial and Chemical Research Laboratories, Industrial Technology Research Institute, Hsinchu 310401, Taiwan.
Yu-Zhen YangMaterial and Chemical Research Laboratories, Industrial Technology Research Institute, Hsinchu 310401, Taiwan.
Chih-Hsin TangSchool of Medicine, China Medical University, Taichung 404022, Taiwan.ORCID 0000-0002-7113-8352
China Medical University · TWIndustrial Technology Research Institute · TWAsia University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoarthritis (OA) is a chronic inflammatory and progressive joint disease that results in cartilage degradation and subchondral bone remodeling. The proinflammatory cytokine interleukin 1 beta (IL-1β) is abundantly expressed in OA and plays a crucial role in cartilage remodeling, although its role in the activity of chondrocytes in cartilage and subchondral remodeling remains unclear. In this study, stimulating chondrogenic ATDC5 cells with IL-1β increased the levels of bone morphogenetic protein 2 (BMP-2), promoted articular cartilage degradation, and enhanced structural remodeling. Immunohistochemistry staining and microcomputed tomography imaging of the subchondral trabecular bone region in the experimental OA rat model revealed that the OA disease promotes levels of IL-1β, BMP-2, and matrix metalloproteinase 13 (MMP-13) expression in the articular cartilage and enhances subchondral bone remodeling. The intra-articular injection of Noggin protein (a BMP-2 inhibitor) attenuated subchondral bone remodeling and disease progression in OA rats. We also found that IL-1β increased BMP-2 expression by activating the mitogen-activated protein kinase (MEK), extracellular signal-regulated kinase (ERK), and specificity protein 1 (Sp1) signaling pathways. We conclude that IL-1β promotes BMP-2 expression in chondrocytes via the MEK/ERK/Sp1 signaling pathways. The administration of Noggin protein reduces the expression of IL-1β and BMP-2, which prevents cartilage degeneration and OA development.

Indexed as

AnimalsBone Morphogenetic Protein 2Bone RemodelingCarrier ProteinsCartilage, ArticularCell LineHumansInterleukin-1betaMaleMiceNoggin ProteinOsteoarthritisRatsRats, Sprague-DawleyTranscriptomeTransfectionBMP2 protein, humanBone Morphogenetic Protein 2Carrier ProteinsIL1B protein, humanInterleukin-1betaNoggin Proteinbone morphogenetic protein 2cartilage remodelinginterleukin-1βosteoarthritis

Identifiers

PMID32290085
PMCPMC7226847
OpenAlexW3015884054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.